Showing results (91-100 of 128) with videos related to
Sort By:
Pageof 13
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanomaMaha Ayyoub, Stefan Stevanovic, Ugur Sahin, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2009
PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patientsJulien Fourcade, Pavol Kudela, Zhaojun Sun, et al.The Journal of Infectious Diseases|July 2, 2016
Environmental Contamination and Persistence of Ebola Virus RNA in an Ebola Treatment CenterPhilippe Guillaume Poliquin, Florian Vogt, Miriam Kasztura, et al.Frontiers in Immunology|October 6, 2025
Regulatory T cell therapy for xenotransplantation, what perspectives?Raphaël Porret, Erica Lana, Antonio Mancarella, et al.The Journal of Pharmacology and Experimental Therapeutics|May 20, 2018
OBE022, an Oral and Selective Prostaglandin F2 Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm LaborOliver Pohl, André Chollet, Sung Hye Kim, et al.International Journal of Cancer|July 29, 2011
Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cellsPetra Baumgaertner, Camilla Jandus, Jean-Paul Rivals, et al.International Immunology|June 25, 2008
Characterization of Melan-A reactive memory CD8+ T cells in a healthy donorVerena Voelter, Nathalie Rufer, Severine Reynard, et al.Iscience|March 23, 2023
Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinityHajer Fritah, Michele Graciotti, Cheryl Lai-Lai Chiang, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
IL-12 controls cytotoxicity of a novel subset of self-antigen-specific human CD28+ cytolytic T cellsCatherine Barbey, Petra Baumgaertner, Estelle Devevre, et al.The Journal of Experimental Medicine|July 18, 2002
Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humansValérie Dutoit, Verena Rubio-Godoy, Mikäel J Pittet, et al.Pageof 13